From the ocean to the pharmacy: harnessing marine biopolymers for drug delivery

Marine biopolymers (MPs) are natural polymers derived from marine organisms such as algae, seaweed, and shellfish. These biopolymers have gained significant attention in recent years due to their biocompatibility, biodegradability, and low toxicity, making them an attractive alternative to synthetic polymers in the delivery of drugs. Drug delivery systems (DDSs) based on MPs have shown promising results in improving drug efficacy, reducing systemic toxicity, and enhancing targeted delivery. MPs have unique properties that allow them to form various DDSs, such as hydrogels, nanoparticles, and micelles. Additionally, these biopolymers possess functional groups that can be easily modified, making them highly versatile for the delivery of drugs. The application of MPs in drug delivery has significant potential for developing new treatments for a range of diseases, including cancer, inflammatory disorders, and infections. This approach is a promising avenue in order to create DDS with greater effectiveness and less toxicity.